Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 420

1.

Characterization of two Pantoea strains isolated from extra-virgin olive oil.

Pizzolante G, Durante M, Rizzo D, Di Salvo M, Tredici SM, Tufariello M, De Paolis A, Talà A, Mita G, Alifano P, De Benedetto GE.

AMB Express. 2018 Jul 10;8(1):113. doi: 10.1186/s13568-018-0642-z.

PMID:
29992518
2.

Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway.

Durante M, Formenti SC.

Front Oncol. 2018 May 29;8:192. doi: 10.3389/fonc.2018.00192. eCollection 2018. Review.

3.

Heavy Charged Particles: Does Improved Precision and Higher Biological Effectiveness Translate to Better Outcome in Patients?

Durante M, Debus J.

Semin Radiat Oncol. 2018 Apr;28(2):160-167. doi: 10.1016/j.semradonc.2017.11.004. Review.

PMID:
29735192
5.

Use of Olive Oil Industrial By-Product for Pasta Enrichment.

Padalino L, D'Antuono I, Durante M, Conte A, Cardinali A, Linsalata V, Mita G, Logrieco AF, Del Nobile MA.

Antioxidants (Basel). 2018 Apr 16;7(4). pii: E59. doi: 10.3390/antiox7040059.

6.

2-Benzylpiperazine: A new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in vivo activity for a new class of intraocular pressure lowering agents.

Chiaramonte N, Bua S, Ferraroni M, Nocentini A, Bonardi A, Bartolucci G, Durante M, Lucarini L, Chiapponi D, Dei S, Manetti D, Teodori E, Gratteri P, Masini E, Supuran CT, Romanelli MN.

Eur J Med Chem. 2018 May 10;151:363-375. doi: 10.1016/j.ejmech.2018.04.002. Epub 2018 Apr 3.

PMID:
29635168
7.

Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study.

Mastrocola R, Ferrocino I, Liberto E, Chiazza F, Cento AS, Collotta D, Querio G, Nigro D, Bitonto V, Cutrin JC, Rantsiou K, Durante M, Masini E, Aragno M, Cordero C, Cocolin L, Collino M.

J Nutr Biochem. 2018 May;55:185-199. doi: 10.1016/j.jnutbio.2018.02.003. Epub 2018 Feb 13.

PMID:
29539590
8.

Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma.

Brownstein JM, Wisdom AJ, Castle KD, Mowery YM, Guida P, Lee CL, Tommasino F, Tessa C, Scifoni E, Gao J, Luo L, Campos LDS, Ma Y, Williams N, Jung SH, Durante M, Kirsch DG.

Mol Cancer Ther. 2018 Apr;17(4):858-868. doi: 10.1158/1535-7163.MCT-17-0965. Epub 2018 Feb 7.

PMID:
29437879
9.

A Carotenoid Extract from a Southern Italian Cultivar of Pumpkin Triggers Nonprotective Autophagy in Malignant Cells.

Russo M, Moccia S, Bilotto S, Spagnuolo C, Durante M, Lenucci MS, Mita G, Volpe MG, Aquino RP, Russo GL.

Oxid Med Cell Longev. 2017;2017:7468538. doi: 10.1155/2017/7468538. Epub 2017 Dec 21.

10.

Clinical Indications for Carbon Ion Radiotherapy.

Mohamad O, Yamada S, Durante M.

Clin Oncol (R Coll Radiol). 2018 May;30(5):317-329. doi: 10.1016/j.clon.2018.01.006.

PMID:
29402598
11.

Punctuated evolution of canonical genomic aberrations in uveal melanoma.

Field MG, Durante MA, Anbunathan H, Cai LZ, Decatur CL, Bowcock AM, Kurtenbach S, Harbour JW.

Nat Commun. 2018 Jan 9;9(1):116. doi: 10.1038/s41467-017-02428-w.

12.

Editorial: Charged Particles in Oncology.

Durante M, Cucinotta FA, Loeffler JS.

Front Oncol. 2017 Dec 8;7:301. doi: 10.3389/fonc.2017.00301. eCollection 2017. No abstract available.

13.

Multidisciplinary European Low Dose Initiative (MELODI): strategic research agenda for low dose radiation risk research.

Kreuzer M, Auvinen A, Cardis E, Durante M, Harms-Ringdahl M, Jourdain JR, Madas BG, Ottolenghi A, Pazzaglia S, Prise KM, Quintens R, Sabatier L, Bouffler S.

Radiat Environ Biophys. 2018 Mar;57(1):5-15. doi: 10.1007/s00411-017-0726-1. Epub 2017 Dec 15. Review.

14.

Immobilization for carbon ion beam ablation of cardiac structures in a porcine model.

Prall M, Eichhorn A, Richter D, Lehmann HI, Constantinescu A, Kaderka R, Lugenbiel P, Thomas D, Bert C, Packer DL, Durante M, Graeff C.

Phys Med. 2017 Nov;43:134-139. doi: 10.1016/j.ejmp.2017.10.016. Epub 2017 Nov 8.

PMID:
29195556
15.

Faster and safer? FLASH ultra-high dose rate in radiotherapy.

Durante M, Bräuer-Krisch E, Hill M.

Br J Radiol. 2018 Feb;91(1082):20170628. doi: 10.1259/bjr.20170628. Epub 2017 Dec 15.

PMID:
29172684
16.

Treatment planning with intensity modulated particle therapy for multiple targets in stage IV non-small cell lung cancer.

Anderle K, Stroom J, Vieira S, Pimentel N, Greco C, Durante M, Graeff C.

Phys Med Biol. 2018 Jan 17;63(2):025034. doi: 10.1088/1361-6560/aa9c62.

PMID:
29165322
17.

Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies.

Yang H, Kurtenbach S, Guo Y, Lohse I, Durante MA, Li J, Li Z, Al-Ali H, Li L, Chen Z, Field MG, Zhang P, Chen S, Yamamoto S, Li Z, Zhou Y, Nimer SD, Harbour JW, Wahlestedt C, Xu M, Yang FC.

Blood. 2018 Jan 18;131(3):328-341. doi: 10.1182/blood-2017-06-789669. Epub 2017 Nov 7.

PMID:
29113963
18.

Modeling Radiation Effects of Ultrasoft X Rays on the Basis of Amorphous Track Structure.

Buch T, Scifoni E, Krämer M, Durante M, Scholz M, Friedrich T.

Radiat Res. 2018 Jan;189(1):32-43. doi: 10.1667/RR14653.1. Epub 2017 Oct 26.

PMID:
29073360
19.

Heart in space: effect of the extraterrestrial environment on the cardiovascular system.

Hughson RL, Helm A, Durante M.

Nat Rev Cardiol. 2018 Mar;15(3):167-180. doi: 10.1038/nrcardio.2017.157. Epub 2017 Oct 20. Review.

PMID:
29053152
20.

Differential Impact of Single-Dose Fe Ion and X-Ray Irradiation on Endothelial Cell Transcriptomic and Proteomic Responses.

Baselet B, Azimzadeh O, Erbeldinger N, Bakshi MV, Dettmering T, Janssen A, Ktitareva S, Lowe DJ, Michaux A, Quintens R, Raj K, Durante M, Fournier C, Benotmane MA, Baatout S, Sonveaux P, Tapio S, Aerts A.

Front Pharmacol. 2017 Sep 22;8:570. doi: 10.3389/fphar.2017.00570. eCollection 2017.

21.

Techno-functional properties of tomato puree fortified with anthocyanin pigments.

Gerardi C, Albano C, Calabriso N, Carluccio MA, Durante M, Mita G, Renna M, Serio F, Blando F.

Food Chem. 2018 Feb 1;240:1184-1192. doi: 10.1016/j.foodchem.2017.08.057. Epub 2017 Aug 18.

PMID:
28946241
22.

Addendum: Measurement of charged particle yields from PMMA irradiated by a 220 MeV/u 12C beam.

Mattei I, Battistoni G, Collini F, De Lucia E, Durante M, Fiore S, Latessa C, Mancini-Terracciano C, Marafini M, Mirabelli R, Muraro S, Paramatti R, Piersanti L, Rucinski A, Russomando A, Sarti A, Schuy C, Sciubba A, Solfaroli Camillocci E, Toppi M, Traini G, Valle SM, Vanstalle M, Patera V.

Phys Med Biol. 2017 Sep 8. doi: 10.1088/1361-6560/aa8b35. [Epub ahead of print]

PMID:
28885189
23.

MC225, a Novel Probe for P-glycoprotein PET Imaging at the Blood-brain Barrier: In Vitro Cardiovascular Safety Evaluation.

Fusi F, Durante M, Gorelli B, Perrone MG, Colabufo NA, Saponara S.

J Cardiovasc Pharmacol. 2017 Dec;70(6):405-410. doi: 10.1097/FJC.0000000000000536.

PMID:
28877068
24.

Oxygen beams for therapy: advanced biological treatment planning and experimental verification.

Sokol O, Scifoni E, Tinganelli W, Kraft-Weyrather W, Wiedemann J, Maier A, Boscolo D, Friedrich T, Brons S, Durante M, Krämer M.

Phys Med Biol. 2017 Sep 20;62(19):7798-7813. doi: 10.1088/1361-6560/aa88a0.

PMID:
28841579
25.

Delfinoia, a new South American aphid genus (Hemiptera, Aphididae, Macrosiphini) on Cayaponia (Cucurbitaceae).

Nafría JMN, Durante MPM, Ciruelos SIL.

Zookeys. 2017 Apr 26;(671):49-60. doi: 10.3897/zookeys.671.12247. eCollection 2017.

26.

In vitro vascular toxicity of tariquidar, a potential tool for in vivo PET studies.

Durante M, Frosini M, Fusi F, Neri A, Sticozzi C, Saponara S.

Toxicol In Vitro. 2017 Oct;44:241-247. doi: 10.1016/j.tiv.2017.07.015. Epub 2017 Jul 23.

PMID:
28746893
27.

ECG-based 4D-dose reconstruction of cardiac arrhythmia ablation with carbon ion beams: application in a porcine model.

Richter D, Lehmann HI, Eichhorn A, Constantinescu AM, Kaderka R, Prall M, Lugenbiel P, Takami M, Thomas D, Bert C, Durante M, Packer DL, Graeff C.

Phys Med Biol. 2017 Aug 4;62(17):6869-6883. doi: 10.1088/1361-6560/aa7b67.

PMID:
28644151
28.

Measuring Leukocyte Adhesion to (Primary) Endothelial Cells after Photon and Charged Particle Exposure with a Dedicated Laminar Flow Chamber.

Erbeldinger N, Rapp F, Ktitareva S, Wendel P, Bothe AS, Dettmering T, Durante M, Friedrich T, Bertulat B, Meyer S, Cardoso MC, Hehlgans S, Rödel F, Fournier C.

Front Immunol. 2017 Jun 1;8:627. doi: 10.3389/fimmu.2017.00627. eCollection 2017.

29.

Identification of the elementary structural units of the DNA damage response.

Natale F, Rapp A, Yu W, Maiser A, Harz H, Scholl A, Grulich S, Anton T, Hörl D, Chen W, Durante M, Taucher-Scholz G, Leonhardt H, Cardoso MC.

Nat Commun. 2017 Jun 12;8:15760. doi: 10.1038/ncomms15760.

30.

Benchmarking Geant4 hadronic models for prompt-γ monitoring in carbon ion therapy.

Vanstalle M, Mattei I, Sarti A, Bellini F, Bini F, Collamati F, Lucia E, Durante M, Faccini R, Ferroni F, Finck C, Fiore S, Marafini M, Patera V, Piersanti L, Rovituso M, Schuy C, Sciubba A, Traini G, Voena C, Tessa C.

Med Phys. 2017 Aug;44(8):4276-4286. doi: 10.1002/mp.12348. Epub 2017 Jun 30.

PMID:
28586136
31.

Evaluation of bioactive compounds in black table olives fermented with selected microbial starters.

Durante M, Tufariello M, Tommasi L, Lenucci MS, Bleve G, Mita G.

J Sci Food Agric. 2018 Jan;98(1):96-103. doi: 10.1002/jsfa.8443. Epub 2017 Jul 5.

PMID:
28543537
32.

The complete 12 Mb genome and transcriptome of Nonomuraea gerenzanensis with new insights into its duplicated "magic" RNA polymerase.

D'Argenio V, Petrillo M, Pasanisi D, Pagliarulo C, Colicchio R, Talà A, de Biase MS, Zanfardino M, Scolamiero E, Pagliuca C, Gaballo A, Cicatiello AG, Cantiello P, Postiglione I, Naso B, Boccia A, Durante M, Cozzuto L, Salvatore P, Paolella G, Salvatore F, Alifano P.

Sci Rep. 2016 Dec 21;6(1):18. doi: 10.1038/s41598-016-0025-0.

33.

A descriptive and broadly applicable model of therapeutic and stray absorbed dose from 6 to 25 MV photon beams.

Schneider CW, Newhauser WD, Wilson LJ, Schneider U, Kaderka R, Miljanić S, Knežević Ž, Stolarcyzk L, Durante M, Harrison RM.

Med Phys. 2017 Jul;44(7):3805-3814. doi: 10.1002/mp.12286. Epub 2017 Jun 1.

PMID:
28429827
34.

Charged-particle therapy in cancer: clinical uses and future perspectives.

Durante M, Orecchia R, Loeffler JS.

Nat Rev Clin Oncol. 2017 Aug;14(8):483-495. doi: 10.1038/nrclinonc.2017.30. Epub 2017 Mar 14. Review.

PMID:
28290489
35.

Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery.

Tommasino F, Durante M, D'Avino V, Liuzzi R, Conson M, Farace P, Palma G, Schwarz M, Cella L, Pacelli R.

Acta Oncol. 2017 May;56(5):730-736. doi: 10.1080/0284186X.2017.1299218. Epub 2017 Mar 10.

PMID:
28281862
36.

The Immunoregulatory Potential of Particle Radiation in Cancer Therapy.

Ebner DK, Tinganelli W, Helm A, Bisio A, Yamada S, Kamada T, Shimokawa T, Durante M.

Front Immunol. 2017 Feb 6;8:99. doi: 10.3389/fimmu.2017.00099. eCollection 2017.

37.

Fragmentation of 120 and 200 MeV u-14He ions in water and PMMA targets.

Rovituso M, Schuy C, Weber U, Brons S, Cortés-Giraldo MA, La Tessa C, Piasetzky E, Izraeli D, Schardt D, Toppi M, Scifoni E, Krämer M, Durante M.

Phys Med Biol. 2017 Feb 21;62(4):1310-1326. doi: 10.1088/1361-6560/aa5302. Epub 2017 Jan 23.

PMID:
28114125
38.

New furoxan derivatives for the treatment of ocular hypertension.

Blangetti M, Rolando B, Chegaev K, Guglielmo S, Lazzarato L, Durante M, Masini E, Almirante N, Bastia E, Impagnatiello F, Fruttero R, Gasco A.

Bioorg Med Chem Lett. 2017 Feb 1;27(3):479-483. doi: 10.1016/j.bmcl.2016.12.041. Epub 2016 Dec 18.

39.

Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams.

Lehmann HI, Graeff C, Simoniello P, Constantinescu A, Takami M, Lugenbiel P, Richter D, Eichhorn A, Prall M, Kaderka R, Fiedler F, Helmbrecht S, Fournier C, Erbeldinger N, Rahm AK, Rivinius R, Thomas D, Katus HA, Johnson SB, Parker KD, Debus J, Asirvatham SJ, Bert C, Durante M, Packer DL.

Sci Rep. 2016 Dec 20;6:38895. doi: 10.1038/srep38895.

40.

Hibernation for space travel: Impact on radioprotection.

Cerri M, Tinganelli W, Negrini M, Helm A, Scifoni E, Tommasino F, Sioli M, Zoccoli A, Durante M.

Life Sci Space Res (Amst). 2016 Nov;11:1-9. doi: 10.1016/j.lssr.2016.09.001. Epub 2016 Sep 13. Review.

PMID:
27993187
41.

Ionizing Radiation Alters Human Embryonic Stem Cell Properties and Differentiation Capacity by Diminishing the Expression of Activin Receptors.

Luft S, Arrizabalaga O, Kulish I, Nasonova E, Durante M, Ritter S, Schroeder IS.

Stem Cells Dev. 2017 Mar 1;26(5):341-352. doi: 10.1089/scd.2016.0277. Epub 2016 Dec 22.

PMID:
27937745
42.

Vascular Toxicity Risk Assessment of MC18 and MC70, Novel Potential Diagnostic Tools for In Vivo PET Studies.

Fusi F, Durante M, Sticozzi C, Frosini M, Perrone MG, Colabufo NA, Saponara S.

Basic Clin Pharmacol Toxicol. 2017 May;120(5):434-441. doi: 10.1111/bcpt.12719. Epub 2017 Jan 16.

43.

Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?

Mizusawa M, Miller H, Green R, Lee R, Durante M, Perkins R, Hewitt C, Simner PJ, Carroll KC, Hayden RT, Zhang SX.

J Clin Microbiol. 2017 Feb;55(2):638-640. doi: 10.1128/JCM.02202-16. Epub 2016 Nov 23. No abstract available.

44.

Does Heavy Ion Therapy Work Through the Immune System?

Durante M, Brenner DJ, Formenti SC.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):934-936. doi: 10.1016/j.ijrobp.2016.08.037. Epub 2016 Sep 5. No abstract available.

PMID:
27869095
45.

Histamine H4 receptor agonist-induced relief from painful peripheral neuropathy is mediated by inhibition of spinal neuroinflammation and oxidative stress.

Sanna MD, Lucarini L, Durante M, Ghelardini C, Masini E, Galeotti N.

Br J Pharmacol. 2017 Jan;174(1):28-40. doi: 10.1111/bph.13644. Epub 2016 Nov 18.

46.

HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.

Lucarini L, Durante M, Lanzi C, Pini A, Boccalini G, Calosi L, Moroni F, Masini E, Mannaioni G.

J Cell Mol Med. 2017 Feb;21(2):324-335. doi: 10.1111/jcmm.12967. Epub 2016 Oct 4.

47.

Response to "Comment on 'Helium ions for radiotherapy? Physical and biological verifications of a novel treatment modality' " [Med. Phys. 43, 1995-2004 (2016)].

Krämer M, Scifoni E, Durante M.

Med Phys. 2016 Sep;43(9):5262. doi: 10.1118/1.4960373. No abstract available.

PMID:
27587058
48.

In silico comparison of photons versus carbon ions in single fraction therapy of lung cancer.

Anderle K, Stroom J, Pimentel N, Greco C, Durante M, Graeff C.

Phys Med. 2016 Sep;32(9):1118-23. doi: 10.1016/j.ejmp.2016.08.014. Epub 2016 Aug 25.

PMID:
27567087
49.

Heavy Ions in Cancer Therapy.

Pompos A, Durante M, Choy H.

JAMA Oncol. 2016 Dec 1;2(12):1539-1540. doi: 10.1001/jamaoncol.2016.2646. No abstract available.

50.

Nuclear physics in particle therapy: a review.

Durante M, Paganetti H.

Rep Prog Phys. 2016 Sep;79(9):096702. doi: 10.1088/0034-4885/79/9/096702. Epub 2016 Aug 19.

PMID:
27540827

Supplemental Content

Loading ...
Support Center